» Articles » PMID: 30413519

Smartphone Problem-solving and Behavioural Activation Therapy to Reduce Fear of Recurrence Among Patients with Breast Cancer (SMartphone Intervention to LEssen Fear of Cancer Recurrence: SMILE Project): Protocol for a Randomised Controlled Trial

Overview
Journal BMJ Open
Specialty General Medicine
Date 2018 Nov 11
PMID 30413519
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: One of the most common distressing conditions experienced by breast cancer survivors is fear of cancer recurrence (FCR). There is, however, no standard intervention for ameliorating FCR. Our clinical experience and previous studies have suggested the potential benefits of problem-solving therapy (PST) and behavioural activation (BA). Given the huge number of cancer survivors and limited number of therapists to competently conduct PST and BA, we have developed PST and BA smartphone applications. This study aimed to evaluate the efficacy of the smartphone-based PST (Kaiketsu-App) and BA (Genki-App) apps in reducing FCR in patients with breast cancer.

Methods And Analysis: The SMartphone Intervention to LEssen fear of cancer recurrence project is an open-label, individually randomised, parallel-group trial. Allocation will be managed by a central server using a computer-generated random allocation sequence provided by an independent data centre. Participants will be randomised to smartphone-based intervention plus treatment as usual (TAU) or waitlist control with TAU alone. The primary endpoint of the study is the Japanese version of the Concerns About Recurrence Scale, which will be administered as an electronic patient-reported outcome on the patients' smartphone after 8 weeks.

Ethics And Dissemination: The present study is subject to the ethical guidelines for clinical studies published by Japan's Ministry of Education, Science and Technology and Ministry of Health, Labour and Welfare and the modified Act on the Protection of Personal Information as well as the ethical principles established for research on humans stipulated in the Declaration of Helsinki and further amendments thereto. The protocol was approved by the Institutional Review Board of Nagoya City University on 15 January 2018 (ID: 60-00-1171).

Trial Status: The randomised trial, which commenced on 2 April 2018, currently enrols participants. The estimated end date for this study is in March 2020.

Trial Registration Number: UMIN000031140; Pre-results.

Citing Articles

Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety....

Uchida M, Furukawa T, Yamaguchi T, Imai F, Momino K, Katsuki F Trials. 2023; 24(1):344.

PMID: 37217965 PMC: 10201730. DOI: 10.1186/s13063-023-07307-y.


Effectiveness of a facilitation programme using a mobile application for initiating advance care planning discussions between patients with advanced cancer and healthcare providers: protocol for a randomised controlled trial (J-SUPPORT 2104).

Obama K, Fujimori M, Okamura M, Kadowaki M, Ueno T, Boku N BMJ Open. 2023; 13(3):e069557.

PMID: 36977536 PMC: 10069562. DOI: 10.1136/bmjopen-2022-069557.


Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study).

Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F J Clin Oncol. 2022; 41(5):1069-1078.

PMID: 36322882 PMC: 9928623. DOI: 10.1200/JCO.22.00699.


Progress on deep learning in digital pathology of breast cancer: a narrative review.

Zhu J, Liu M, Li X Gland Surg. 2022; 11(4):751-766.

PMID: 35531111 PMC: 9068546. DOI: 10.21037/gs-22-11.


Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors.

Pradhan P, Sharpe L, Menzies R Cancer Manag Res. 2021; 13:8953-8965.

PMID: 34880676 PMC: 8645945. DOI: 10.2147/CMAR.S294114.


References
1.
Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013; 346:e7586. PMC: 3541470. DOI: 10.1136/bmj.e7586. View

2.
Koch L, Jansen L, Brenner H, Arndt V . Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology. 2012; 22(1):1-11. DOI: 10.1002/pon.3022. View

3.
Ito Y, Miyashiro I, Ito H, Hosono S, Chihara D, Nakata-Yamada K . Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 2014; 105(11):1480-6. PMC: 4462379. DOI: 10.1111/cas.12525. View

4.
So M, Yamaguchi S, Hashimoto S, Sado M, Furukawa T, McCrone P . Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity. BMC Psychiatry. 2013; 13:113. PMC: 3638010. DOI: 10.1186/1471-244X-13-113. View

5.
Tedeschi R, Calhoun L . The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996; 9(3):455-71. DOI: 10.1007/BF02103658. View